Hims & Hers Health stock surged after Super Bowl ad promoting weight-loss drugs.

From Nasdaq: 2025-02-10 19:13:00

Healthcare stocks Novo Nordisk and Viking Therapeutics dropped while Hims & Hers Healthcare surged. Hims & Hers ran a Super Bowl ad promoting their weight-loss drugs, although they are a telehealth retailer, not a developer. Novo Nordisk and Viking are actively developing obesity treatments. Investors should not overreact to marketing tactics, as the FDA may intervene. For potential investment opportunities, consider “Double Down” stock recommendations from experts for companies poised to grow. Don’t miss out on potential gains with timely investments.



Read more at Nasdaq: Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today